Seeing beyond words: nanotechnology in hepatocellular carcinoma - a bibliometric study

Talaiti Tuergan; Talaiti Tuergan; Aimitaji Abulaiti; Alimu Tulahong; Alimu Tulahong; Ruiqing Zhang; Ruiqing Zhang; Zhongdian Yuan; Zhongdian Yuan; Yanze Lin; Yanze Lin; Yingmei Shao; Yingmei Shao; Yingmei Shao; Tuerganaili Aji; Tuerganaili Aji

doi:10.3389/fonc.2024.1487198

Frontiers in Oncology (Jan 2025)

Seeing beyond words: nanotechnology in hepatocellular carcinoma - a bibliometric study

Talaiti Tuergan,
Talaiti Tuergan,
Aimitaji Abulaiti,
Alimu Tulahong,
Alimu Tulahong,
Ruiqing Zhang,
Ruiqing Zhang,
Zhongdian Yuan,
Zhongdian Yuan,
Yanze Lin,
Yanze Lin,
Yingmei Shao,
Yingmei Shao,
Yingmei Shao,
Tuerganaili Aji,
Tuerganaili Aji

Affiliations

Talaiti Tuergan: Hepatobiliary and Echinococcosis Surgery Department, Digestive and Vascular Surgery Center, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
Talaiti Tuergan: State Key Laboratory of Pathogenesis, Prevention and Management of High Incidence Diseases in Central Asia, Xinjiang Medical University, Urumqi, China
Aimitaji Abulaiti: Hepatobiliary and Echinococcosis Surgery Department, Digestive and Vascular Surgery Center, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
Alimu Tulahong: Hepatobiliary and Echinococcosis Surgery Department, Digestive and Vascular Surgery Center, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
Alimu Tulahong: State Key Laboratory of Pathogenesis, Prevention and Management of High Incidence Diseases in Central Asia, Xinjiang Medical University, Urumqi, China
Ruiqing Zhang: Hepatobiliary and Echinococcosis Surgery Department, Digestive and Vascular Surgery Center, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
Ruiqing Zhang: State Key Laboratory of Pathogenesis, Prevention and Management of High Incidence Diseases in Central Asia, Xinjiang Medical University, Urumqi, China
Zhongdian Yuan: Hepatobiliary and Echinococcosis Surgery Department, Digestive and Vascular Surgery Center, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
Zhongdian Yuan: State Key Laboratory of Pathogenesis, Prevention and Management of High Incidence Diseases in Central Asia, Xinjiang Medical University, Urumqi, China
Yanze Lin: Hepatobiliary and Echinococcosis Surgery Department, Digestive and Vascular Surgery Center, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
Yanze Lin: State Key Laboratory of Pathogenesis, Prevention and Management of High Incidence Diseases in Central Asia, Xinjiang Medical University, Urumqi, China
Yingmei Shao: Hepatobiliary and Echinococcosis Surgery Department, Digestive and Vascular Surgery Center, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
Yingmei Shao: State Key Laboratory of Pathogenesis, Prevention and Management of High Incidence Diseases in Central Asia, Xinjiang Medical University, Urumqi, China
Yingmei Shao: Xinjiang Clinical Research Center for Echinococcosis and Hepatobiliary Diseases, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
Tuerganaili Aji: Hepatobiliary and Echinococcosis Surgery Department, Digestive and Vascular Surgery Center, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
Tuerganaili Aji: State Key Laboratory of Pathogenesis, Prevention and Management of High Incidence Diseases in Central Asia, Xinjiang Medical University, Urumqi, China

DOI: https://doi.org/10.3389/fonc.2024.1487198
Journal volume & issue: Vol. 14

Abstract

Read online

BackgroundNanotechnology has increasingly been applied in the diagnosis and treatment of hepatocellular carcinoma (HCC) over the past two decades. This study aims to explore the utilization of nanotechnology in HCC through a bibliometric analysis, identifying key themes, trends, and contributions in this field.MethodsThe study utilized VOSviewer and CiteSpace software to perform a bibliometric analysis, evaluating scholarly contributions related to nanotechnology in HCC. The analysis focused on co-occurrence network relationships, publications, citations, and contributions from various entities and authors.ResultsThe analysis revealed a total of 2,968 articles, with China and the USA being the most prominent contributors in terms of publications and citations. Notable contributions were made by the Chinese Academy of Sciences and authors Gao Jie and Li Yan. LLOVET JM emerged as the most co-cited author, indicating a leadership role in the field. The “International Journal of Nanomedicine” was identified as the leading publisher, while “Biomaterials” ranked highest in citations. The research mainly focused on drug delivery systems and apoptosis, highlighting significant advancements in utilizing nanotechnology for HCC treatment.ConclusionThis bibliometric study underscores the critical role of nanotechnology in advancing the diagnosis and treatment of hepatocellular carcinoma, with a particular emphasis on drug delivery and apoptosis. The findings highlight the contributions of key countries, institutions, and authors, reflecting the global effort and collaboration in this rapidly evolving field.

Published in Frontiers in Oncology

ISSN: 2234-943X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.frontiersin.org/journals/oncology/

About the journal

Abstract

Keywords